151 related articles for article (PubMed ID: 32325008)
21. Receptor tyrosine kinase, RON, promotes tumor progression by regulating EMT and the MAPK signaling pathway in human oral squamous cell carcinoma.
Kim SA; Lee KH; Lee DH; Lee JK; Lim SC; Joo YE; Chung IJ; Noh MG; Yoon TM
Int J Oncol; 2019 Aug; 55(2):513-526. PubMed ID: 31268163
[TBL] [Abstract][Full Text] [Related]
22. [Advances in Hippo signaling pathway in oral squamous cell carcinoma].
Xu WQ; Xu XH; Liu C; Yao LL; Wang XM
Zhonghua Kou Qiang Yi Xue Za Zhi; 2021 Feb; 56(2):221-225. PubMed ID: 33557511
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
Li GH; Ma ZH; Wang X
Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
[TBL] [Abstract][Full Text] [Related]
24. Repression of G protein-coupled receptor family C group 5 member A is associated with pathologic differentiation grade of oral squamous cell carcinoma.
Liu SL; Zhong SS; Ye DX; Chen WT; Zhang ZY; Deng J
J Oral Pathol Med; 2013 Nov; 42(10):761-8. PubMed ID: 23651229
[TBL] [Abstract][Full Text] [Related]
25. The Zinc Sensing Receptor, ZnR/GPR39, in Health and Disease.
Hershfinkel M
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389900
[TBL] [Abstract][Full Text] [Related]
26. HH/GLI signalling as a new therapeutic target for patients with oral squamous cell carcinoma.
Yan M; Wang L; Zuo H; Zhang Z; Chen W; Mao L; Zhang P
Oral Oncol; 2011 Jun; 47(6):504-9. PubMed ID: 21536478
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic potential of targeting cell division cycle associated 5 for oral squamous cell carcinoma.
Tokuzen N; Nakashiro K; Tanaka H; Iwamoto K; Hamakawa H
Oncotarget; 2016 Jan; 7(3):2343-53. PubMed ID: 26497678
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
Cai Z; Hao XY; Liu FX
Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
[TBL] [Abstract][Full Text] [Related]
29. Hippo Pathway and YAP Signaling Alterations in Squamous Cancer of the Head and Neck.
Santos-de-Frutos K; Segrelles C; Lorz C
J Clin Med; 2019 Dec; 8(12):. PubMed ID: 31817001
[TBL] [Abstract][Full Text] [Related]
30. Anti-oral Squamous Cell Carcinoma Effects of a Potent TAZ Inhibitor AR-42.
Su L; Wang S; Yuan T; Xie X; Fu X; Ji P; Zhong L; Liu W
J Cancer; 2020; 11(2):364-373. PubMed ID: 31897232
[TBL] [Abstract][Full Text] [Related]
31. Zinc regulates vascular endothelial cell activity through zinc-sensing receptor ZnR/GPR39.
Zhu D; Su Y; Zheng Y; Fu B; Tang L; Qin YX
Am J Physiol Cell Physiol; 2018 Apr; 314(4):C404-C414. PubMed ID: 29351417
[TBL] [Abstract][Full Text] [Related]
32. Potential role of differentially expressed lncRNAs in the pathogenesis of oral squamous cell carcinoma.
Zhang S; Tian L; Ma P; Sun Q; Zhang K; GuanchaoWang ; Liu H; Xu B
Arch Oral Biol; 2015 Oct; 60(10):1581-7. PubMed ID: 26276270
[TBL] [Abstract][Full Text] [Related]
33. Long intergenic non-coding RNA 668 regulates VEGFA signaling through inhibition of miR-297 in oral squamous cell carcinoma.
Zhang CZ
Biochem Biophys Res Commun; 2017 Aug; 489(4):404-412. PubMed ID: 28564590
[TBL] [Abstract][Full Text] [Related]
34. Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor.
Shida-Sakazume T; Endo-Sakamoto Y; Unozawa M; Fukumoto C; Shimada K; Kasamatsu A; Ogawara K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2015; 10(3):e0120143. PubMed ID: 25803864
[TBL] [Abstract][Full Text] [Related]
35. MiR-155-5p promotes oral cancer progression by targeting chromatin remodeling gene ARID2.
Wu M; Duan Q; Liu X; Zhang P; Fu Y; Zhang Z; Liu L; Cheng J; Jiang H
Biomed Pharmacother; 2020 Feb; 122():109696. PubMed ID: 31918270
[TBL] [Abstract][Full Text] [Related]
36. Characterization of STAT3 expression, signaling and inhibition in feline oral squamous cell carcinoma.
Brown ME; Bear MD; Rosol TJ; Premanandan C; Kisseberth WC; London CA
BMC Vet Res; 2015 Aug; 11():206. PubMed ID: 26272737
[TBL] [Abstract][Full Text] [Related]
37. YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes.
Mizuno T; Murakami H; Fujii M; Ishiguro F; Tanaka I; Kondo Y; Akatsuka S; Toyokuni S; Yokoi K; Osada H; Sekido Y
Oncogene; 2012 Dec; 31(49):5117-22. PubMed ID: 22286761
[TBL] [Abstract][Full Text] [Related]
38. GALNT2 enhances migration and invasion of oral squamous cell carcinoma by regulating EGFR glycosylation and activity.
Lin MC; Huang MJ; Liu CH; Yang TL; Huang MC
Oral Oncol; 2014 May; 50(5):478-84. PubMed ID: 24582885
[TBL] [Abstract][Full Text] [Related]
39. The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer.
Li Z; Wang Y; Zhu Y; Yuan C; Wang D; Zhang W; Qi B; Qiu J; Song X; Ye J; Wu H; Jiang H; Liu L; Zhang Y; Song LN; Yang J; Cheng J
Mol Oncol; 2015 Jun; 9(6):1091-105. PubMed ID: 25704916
[TBL] [Abstract][Full Text] [Related]
40. Zac1/GPR39 phosphorylating CaMK-II contributes to the distinct roles of Pax3 and Pax7 in myogenic progression.
Yang Q; Li Y; Zhang X; Chen D
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):407-419. PubMed ID: 29079520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
